A detailed history of Opaleye Management Inc. transactions in Harrow Health, Inc. stock. As of the latest transaction made, Opaleye Management Inc. holds 3,990,000 shares of HROW stock, worth $135 Million. This represents 32.75% of its overall portfolio holdings.

Number of Shares
3,990,000
Previous 3,990,000 -0.0%
Holding current value
$135 Million
Previous $83.4 Million 115.22%
% of portfolio
32.75%
Previous 21.35%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$10.0 - $21.64 $694,000 - $1.5 Million
69,400 Added 1.77%
3,990,000 $83.4 Million
Q1 2024

May 15, 2024

BUY
$9.3 - $13.23 $935,580 - $1.33 Million
100,600 Added 2.63%
3,920,600 $51.9 Million
Q4 2023

Feb 14, 2024

BUY
$8.1 - $16.36 $202,500 - $409,000
25,000 Added 0.66%
3,820,000 $42.8 Million
Q3 2023

Nov 14, 2023

BUY
$14.03 - $22.08 $280,600 - $441,599
20,000 Added 0.53%
3,795,000 $54.5 Million
Q4 2022

Feb 10, 2023

BUY
$10.28 - $14.78 $4.43 Million - $6.37 Million
431,183 Added 12.89%
3,775,000 $55.7 Million
Q3 2022

Nov 14, 2022

BUY
$6.57 - $24.88 $72,828 - $275,794
11,085 Added 0.33%
3,343,817 $40.4 Million
Q2 2022

Aug 15, 2022

BUY
$5.75 - $7.74 $237,986 - $320,350
41,389 Added 1.26%
3,332,732 $24.3 Million
Q1 2022

May 16, 2022

BUY
$6.77 - $8.66 $42,942 - $54,930
6,343 Added 0.19%
3,291,343 $22.4 Million
Q3 2021

Nov 16, 2021

BUY
$6.99 - $10.6 $1.01 Million - $1.54 Million
145,000 Added 4.62%
3,285,000 $29.9 Million
Q2 2021

Aug 16, 2021

BUY
$6.68 - $11.07 $498,221 - $825,644
74,584 Added 2.43%
3,140,000 $29.2 Million
Q4 2020

Feb 12, 2021

BUY
$4.76 - $6.93 $506,540 - $737,462
106,416 Added 3.6%
3,065,416 $21 Million
Q3 2020

Nov 16, 2020

BUY
$4.71 - $7.36 $1.17 Million - $1.83 Million
249,000 Added 9.19%
2,959,000 $16.5 Million
Q2 2020

Aug 14, 2020

BUY
$3.61 - $6.47 $9.78 Million - $17.5 Million
2,710,000 New
2,710,000 $14.1 Million

Others Institutions Holding HROW

About HARROW HEALTH, INC.


  • Ticker HROW
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 27,070,000
  • Market Cap $916M
  • Description
  • Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...
More about HROW
Track This Portfolio

Track Opaleye Management Inc. Portfolio

Follow Opaleye Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Opaleye Management Inc. with notifications on news.